Legal Commentator
Leading Litigator
Lead Negotiator

“Negotiated over $2.75 Billion in opioid harm reduction for the State of Texas ”

Jeffrey B. Simon Wins 'Best Attorney' Award 4 Years In A Row.

Jeffrey B. Simon is a commentator and founding partner of SIMON GREENSTONE PANATIER, PC. Ranked as one of the Top 10 Personal Injury Attorney's within America and Co-chair of the National Opioid Litigation Conference, Mr. Simon brings together medical, legal, and law experts to reduce the social and economic harms of the opioid pandemic.

Attorney Jeffrey B. Simon Secures $1.8 Billion Opioid Settlement for All Texans

Jeffrey B. Simon announced that he and a committee of trial lawyers, along with the Office of the Texas Attorney General, have reached a historic $1.8 billion settlement for Texas.

Texas reaches $290 million settlement with Johnson & Johnson

A $290 million settlement agreement Tuesday with pharmaceutical giant Johnson & Johnson over what the state claims were deceptive marketing tactics that contributed to the ongoing opioid crisis.

We're Suing Fossil Fuel Companies for $1.15 Billion

This industrially caused environmental disease will cause enormous harm, both in terms of human suffering...


Thank you to @TheSun for the great discussion I had with them about the DOJ anti-trust case against #Ticketmaster. @taylorswift13 #swiftie #fairness

My doctor said a carb-free diet would prolong my life. But refraining from these #biscuits is killing my #soul. #cantwin #carbs #Bubbas #health #catch22 #sigh #Imean #welp #biscuitsandgravy

Two nights ago at a lovely dinner, I ordered a Kobe hotdog (see pic) that was longer than the putt that Rory just missed on 18 at the US Open. The crushing the world’s best players. I love #golf!

I’ve spent a professional lifetime trying to uphold the rule of law, without fear or favor. POTUS’ son stands trial. If convicted on all counts, he could serve 25 yrs jail. Mr. Biden has not complained about the trial, nor claimed any unfairness. He has said publicly he will not…

Load More


In the news